Retinopathy of Prematurity (ROP)
Classification, Risk Factors & Treatment
Seiten
2015
Nova Science Publishers Inc (Verlag)
978-1-63482-644-0 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63482-644-0 (ISBN)
Retinopathy of prematurity is a disease caused by abnormal vessel regression of the retinal vasculature that affects premature infants with low birth weights. Despite significant improvements in screening guidelines and treatment modalties, ROP is still the leading cause of reversible paediatric blindness worldwide. The authors of this book explore the possibility of applying the concept of fractal analysis to images of retinal blood vessels for morphometric analysis and classification; the quality of life for children with retinopathy of prematurity; the differences in ethnicity and socioeconomic status that influence the prevalence, risks, outcome and management of ROP; the outcome and prognostic factors of the intravitreal administration of bevacizumab for ROP; the outcomes of transpupillary diode laser photocoagulation for ROP; new therapeutic strategies for treating ROP and late complications that can develop and persistent into later childhood and even adult life (for example, long-term refractive errors, amblyopia, strabismus and optic nerve abnormalities).
For Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php?products_id=54578
Erscheint lt. Verlag | 1.6.2015 |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 155 x 230 mm |
Gewicht | 382 g |
Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Augenheilkunde | |
ISBN-10 | 1-63482-644-2 / 1634826442 |
ISBN-13 | 978-1-63482-644-0 / 9781634826440 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Ein systematischer Ansatz
Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 369,95